Edesa Biotech, Inc.(EDSA)
Biotechnology
Immunology & Autoimmune Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-03-11 | Brooks Michael J President | Purchase | +2,000 | +0.89%226,870 | $1.57 | $3,140 | View SEC filing | |
| 2026-03-10 | Nijhawan Pardeep Chief Executive Officer | Purchase | +1,000 | +0.16%628,813 | $6.60 | $6,599 | View SEC filing | |
| 2026-03-06 | Nijhawan Pardeep Chief Executive Officer | Purchase | +10,000 | +2.55%402,702 | $3.90 | $39,000 | View SEC filing | |
| 2026-03-05 | Nijhawan Pardeep Chief Executive Officer | Purchase | +10,000 | +2.61%392,702 | $4.26 | $42,560 | View SEC filing | |
| 2026-03-04 | Nijhawan Pardeep Chief Executive Officer | Purchase | +10,000 | +2.68%382,702 | $3.63 | $36,300 | View SEC filing | |
| 2026-03-03 | Nijhawan Pardeep Chief Executive Officer | Purchase | +3,000 | +0.30%1,000,515 | $2.09 | $6,280 | View SEC filing | |
| 2026-03-02 | Nijhawan Pardeep Chief Executive Officer | Purchase | +50,571 | +5.40%987,499 | $1.96 | $99,176 | View SEC filing | |
| 2024-03-25 | Nijhawan Pardeep Chief Executive Officer | Purchase | +5,000 | +1.48%341,702 | $4.00 | $20,000 | View SEC filing | |
| 2023-01-11 | Lumira Capital Investment Management Inc. 10% Owner | Sale | -297,474 | -14.35%1,775,408 | $2.65 | $787,716 | View SEC filing | |
| 2022-07-05 | Nijhawan Pardeep Chief Executive Officer | Purchase | +20,000 | +3.48%594,812 | $1.60 | $32,078 | View SEC filing | |
| 2022-06-30 | Brooks Michael J President | Purchase | +3,000 | +12.91%26,241 | $1.49 | $4,483 | View SEC filing | |
| 2022-06-21 | Brooks Michael J President | Purchase | +3,000 | +14.82%23,241 | $1.61 | $4,817 | View SEC filing | |
| 2022-05-31 | Nijhawan Pardeep Chief Executive Officer | Purchase | +5,000 | +0.88%574,812 | $1.92 | $9,599 | View SEC filing | |
| 2022-05-26 | Brooks Michael J President | Purchase | +3,500 | +20.91%20,241 | $1.74 | $6,090 | View SEC filing | |
| 2022-05-25 | Nijhawan Pardeep Chief Executive Officer | Purchase | +2,000 | +0.35%569,812 | $1.80 | $3,600 | View SEC filing | |
| 2022-04-01 | Nijhawan Pardeep Chief Executive Officer | Purchase | +2,000 | +0.35%567,812 | $2.99 | $5,972 | View SEC filing | |
| 2022-03-31 | Nijhawan Pardeep Chief Executive Officer | Purchase | +2,000 | +0.35%565,812 | $3.05 | $6,098 | View SEC filing | |
| 2022-03-30 | Nijhawan Pardeep Chief Executive Officer | Purchase | +2,000 | +0.36%563,812 | $3.02 | $6,034 | View SEC filing | |
| 2022-03-21 | Nijhawan Pardeep Chief Executive Officer | Purchase | +2,000 | +0.36%561,812 | $3.85 | $7,699 | View SEC filing | |
| 2022-03-18 | Nijhawan Pardeep Chief Executive Officer | Purchase | +2,000 | +0.36%559,812 | $3.26 | $6,522 | View SEC filing | |
| 2022-03-16 | Nijhawan Pardeep Chief Executive Officer | Purchase | +2,000 | +0.36%557,812 | $2.80 | $5,598 | View SEC filing | |
| 2022-03-15 | Brooks Michael J President | Purchase | +1,250 | +8.07%16,741 | $2.79 | $3,487 | View SEC filing | |
| 2022-03-14 | Nijhawan Pardeep Chief Executive Officer | Purchase | +7,000 | +1.28%555,812 | $3.09 | $21,652 | View SEC filing | |
| 2022-03-11 | Brooks Michael J President | Purchase | +1,000 | +6.90%15,491 | $3.22 | $3,223 | View SEC filing | |
| 2022-03-10 | Nijhawan Pardeep Chief Executive Officer | Purchase | +1,500 | +0.27%548,812 | $3.05 | $4,570 | View SEC filing |
1-25 of 45